SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                     FORM 15

Certification and Notice of Termination of Registration under Section 12(g) of
the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under
Sections 13 and 15(d) of the Securities Exchange Act of 1934.

              Commission File Number                0-26758

                        ALKERMES CLINICAL PARTNERS, L.P.
           ----------------------------------------------------------
             (Exact name of registrant as specified in its charter)

                                88 Sidney Street
                         Cambridge, Massachusetts 02139
                                 (617) 494-0171
                      ------------------------------------
         (Address, including zip code, and telephone number, including
             area code, of registrant's principal executive offices)

                      Class A Limited Partnership Interest
         ---------------------------------------------------------------
            (Title of each class of securities covered by this Form)


                                      None
                      ------------------------------------
       (Titles of all other classes of securities for which a duty to file
                  reports under Section 13(a) or 15(d) remains)

      Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)(i)     [X]                         Rule 12h-3(b)(1)(ii)     [ ]
Rule 12g-4(a)(1)(ii)    [ ]                         Rule 12h-3(b)(2)(i)      [ ]
Rule 12g-4(a)(2)(i)     [ ]                         Rule 12h-3(b)(2)(ii)     [ ]
Rule 12g-4(a)(2)(ii)    [ ]                         Rule 15d-6               [ ]
Rule 12h-3(b)(1)(i)     [ ]

      Approximate number of holders of record as of the certification or
notice date: 0

      Pursuant to the requirements of the Securities Exchange Act of 1934,
Alkermes Clinical Partners, L.P. has caused this certification/notice to be
signed on its behalf by the undersigned duly authorized person.

                                   By:   Alkermes Development Corporation II,
                                         General Partner

Date: December 23, 2003            By:  /s/  James M. Frates
                                       ---------------------------------
                                         James M. Frates
                                         Chief Financial Officer, Vice President
                                         Treasurer and Assistant Secretary